Cost effectiveness analysis for nursing research

Nursing Research

Volumn 62, Issue 4, 2013, Pages 279-285

  Bensink, Mark E ^a   Eaton, Linda H ^a   Morrison, Megan L ^b   Cook, Wendy A ^a   Curtis, R Randall ^a   Gordon, Deborah B ^a   Kundu, Anjana ^a   Doorenbos, Ardith Z ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NORTHWEST HOSPITAL   (United States)

Author keywords

cluster randomized clinical trial; cost effectiveness; pain management; rural health

Indexed keywords

ANALGESIA; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; NURSING; NURSING RESEARCH; RANDOMIZED CONTROLLED TRIAL; RURAL POPULATION; UNITED STATES;

COST-BENEFIT ANALYSIS; HUMANS; NURSING RESEARCH; PAIN MANAGEMENT; RURAL POPULATION; UNITED STATES;

EID: 84879934516     PISSN: 00296562     EISSN: 15389847     Source Type: Journal    
DOI: 10.1097/NNR.0b013e318298b0be     Document Type: Article

References (45)

1. Baldwin, L. M., Patanian, M. M., Larson, E. H., Lishner, D. M., Mauksch, L. B., Katon, W. J., I Hart, L. G. (2006). Modeling the mental health workforce in Washington State: Using state licensing data to examine provider supply in rural and urban areas. Journal of Rural Health, 22, 50-58.
2. Bensink,M.E., Scuffham, P. A.,&Smith, A. C. (2012). Health economics. In H. P. Soyer, M. Binder, A. C. Smith, & E. M. T. Wurm (Eds.), Telemedicine in dermatology (pp. 167Y185). New York, NY: Springer.
3. Berenson, R. A., & Rich, E. C. (2010). U.S. approaches to physician payment: The deconstruction of primary care. Journal of General Internal Medicine, 25, 613-618.
4. Black, W. C. (1990). The CE plane: A graphic representation of cost effectiveness. Medical Decision Making, 10, 212-214. (Pubitemid 20311440)
5. Briggs, A., Wonderling, D., & Mooney, C. (1997). Pulling cost effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Economics, 6, 327-340. (Pubitemid 27384638)
6. Centers for Medicare & Medicaid Services. (2012). Medicare Program; payment policies under the physician fee schedule. Baltimore, MD: Department of Health and Human Services.
7. Centre for Evidence-Based Medicine. (2009). Asking focused questions. Retrieved from http://www.cebm.net/index .aspx?o=1036
8. Drummond, M. F., Sculpher, M. J., Torrance, G. W., O'Brien, B. J., & Stoddart, G. L. (2005). Methods for the economic evaluation of health care programmes (3rd ed.). Oxford, UK: Oxford University Press.
9. Feeny, D., Furlong, W., Boyle, M., & Torrance, G. W. (1995). Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics, 7, 490-502.
10. Fenwick, E., & Byford, S. (2005). A guide to cost effectiveness acceptability curves [editorial]. British Journal of Psychiatry, 187, 106-108. (Pubitemid 41139681)
11. Fisher, E. S., Bynum, J. P., & Skinner, J. S. (2009). Slowing the growth of health care costsVLessons from regional variation. New England Journal of Medicine, 360, 849-852.
12. Franks, P., Hanmer, J., & Fryback, D. G. (2006). Relative disutilities of 47 risk factors and conditions assessed with seven preference-based health status measures in a national U.S. sample: Toward consistency in cost effectiveness analyses. Medical Care, 44, 478-485. (Pubitemid 43755428)
13. Furlong, W. J., Feeny, D. H., Torrance, G. W., & Barr, R. D. (2001). The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Annals of Medicine, 33, 375-384. (Pubitemid 32675379)
14. Glick, H., Doshi, J. A., Sonnad, S. S., & Polsky, D. (2007). Economic evaluation in clinical trials. Oxford, UK: Oxford University Press.
15. Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost effectiveness in health and medicine. Oxford, UK: Oxford University Press.
16. Gomes, M., Grieve, R., Nixon, R., & Edmunds, W. J. (2012). Statistical methods for cost effectiveness analyses that use data from cluster randomized trials: A systematic review and checklist for critical appraisal. Medical Decision Making, 32, 209-220.
17. Goroll, A. H., & Schoenbaum, S. C. (2012). Payment reform for primary care within the accountable care organization: A critical issue for health system reform. Journal of the American Medical Association, 308, 577-578.
18. Hart, M. A. (2012). Accountable care organizations: The future of care delivery? American Journal of Nursing, 112(2), 23-26.
19. Health Resources and Services Administration. (2013). Rural health. Retrieved from http://www.hrsa.gov/ruralhealth/policy/definition-of-rural.html
20. Hersh, W., Helfand, M., Wallace, J., Kraemer, D., Patterson, P., Shapiro, S., & Greenlick, M. (2002). A systematic review of the efficacy of telemedicine for making diagnostic and management decisions. Journal of Telemedicine and Telecare, 8, 197-209.
21. Hersh, W. R., Hickam, D. H., Severance, S. M., Dana, T. L., Pyle Krages, K., & Helfand, M. (2006). Diagnosis, access and outcomes: Update of a systematic review of telemedicine services. Journal of Telemedicine and Telecare, 12(Suppl 2), S3YS31.
22. Horsman, J., Furlong, W., Feeny, D., & Torrance, G. (2003). The Health Utilities Index (HUI): Concepts, measurement properties and applications. Health and Quality of Life Outcomes, 1, 54. doi: 10.1186/1477-7525-1181-1154.
23. Jukkala, A.M., Henly, S. J.,&Lindeke, L. L. (2008). Rural perceptions of continuing professional education. Journal of Continuing Education in Nursing, 39, 555-563.
24. Lubetkin, E. I., & Gold, M. R. (2002). Comprehensibility of measures of health-related quality of life in minority and low-income patients. Journal of the National Medical Association, 94, 327-335.
25. Malone, D. C. (2005). The role of pharmacoeconomic modeling in evidence-based and value-based formulary guidelines. Journal of Managed Care Pharmacy, 11(4 Suppl), S7YS10.
26. McMahon, L. F. Jr., & Chopra, V. (2012). Health care cost and value: The way forward. Journal of the American Medical Association, 307, 671-672.
27. Neumann, P. J. (2004). Evidence-based and value-based formulary guidelines. Health Affairs, 23, 124-134. (Pubitemid 39115292)
28. Nord, E., Daniels, N., & Kamlet, M. (2009). QALYs: Some challenges. Value in Health, 12(Suppl 1), S10YS15.
29. Polsky, D., Glick, H.A, Willke, R., & Schulman, K. (1997). Confidence intervals for cost effectiveness ratios: A comparison of four methods. Health Economics, 6, 243-252. (Pubitemid 27296588)
30. Ramsey, S., Wilke, R., Briggs, A., Brown, R., Buxton, M., Chawla, A., I Reed, S. (2005). Good research practice for cost effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA Task Force report. Value in Health, 8, 521-533. (Pubitemid 41727304)
31. Rä sänen, P., Roine, E., Sintonen, H., Semberg-Konttinen, V., Ryynanen, O. P., & Roine, R. (2006). Use of qualityadjusted life years for the estimation of effectiveness of health care: A systematic literature review. International Journal of Technology Assessment in Health Care, 22, 235-241.
32. Raudenbush, S., Bryk, A., Cheong, Y., & Congdon, R. J. (2004). HLM 6: Hierarchical linear and nonlinear modeling. Lincolnwood, IL: Scientific Software.
33. Rhodes, R., Battin, M. P., & Silvers, A. (Eds.). (2012). Medicine and social justice: Essays on the distribution of health care (2nd ed.). Oxford, UK: Oxford University Press.
34. Rosenthal, T. C., & Fox, C. (2000). Access to health care for the rural elderly. Journal of the American Medical Association, 284, 2034-2036.
35. Sommers, B. D., & Bindman, A. B. (2012). New physicians, the Affordable Care Act, and the changing practice of medicine. Journal of the American Medical Association, 307, 1697-1698.
36. Spitzer, R. L., Kroenke, K.,&Williams, J. B. (1999). Validation and utility of a selfreport version of PRIME-MD: The PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. Journal of the American Medical Association, 282, 1737-1744. (Pubitemid 29533604)
37. Spitzer, R. L., Kroenke, K., Williams, J. B., & Lowe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166, 1092-1097. (Pubitemid 43765180)
38. Steiner, C., Elixhauser, A., & Schnaier, J. (2002). The healthcare cost and utilization project: An overview. Effective Clinical Practice, 5, 143-151.
39. Thompson, S. G., & Barber, J. (2000). How should cost data in pragmatic randomised trials be analysed? British Medical Journal, 320, 1197-1200. (Pubitemid 30224273)
40. Trice, S., Devine, J., Mistry, H., Moore, E., & Linton, A. (2009). Formulary management in the Department of Defense. Journal of Managed Care Pharmacy, 15, 133-146.
41. U.S. Congress. (2010). Patient Protection and Affordable Care Act. Pub. L. No. 111Y148, 124 Stat. 119.
42. U.S. Department of Health and Human Services. (2011). Report to Congress: National strategy for quality improvement in health care. Washington DC. Retrieved from http://www.healthcare .gov/news/reports/quality03212011a.html
43. Weart, W., & Bauman, G. R. (2007). The case for a value-based formulary: Striving for total lowest net cost. Managed Care Interface, 20(4), 42-47. (Pubitemid 46640555)
44. Weinstein, M. C., Siegel, J. E., Gold, M. R., Kamlet, M. S., & Russell, L. B. (1996). Recommendations of the Panel on Cost effectiveness in Health and Medicine. Journal of the American Medical Association, 276, 1253-1258. (Pubitemid 26337709)
45. Weinstein, M. C., Torrance, G.,&McGuire, A. (2009). QALYs: The basics. Value Health, 12(Suppl 1), S5YS9.